These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 1376008)

  • 1. Behavior of epithelial differentiation antigens (carcinoembryonic antigen, epithelial membrane antigen, keratin and cytokeratin) in transitional cell carcinomas of the bladder.
    Sánchez-Fernández de Sevilla MC; Morell-Quadreny L; Gil-Salom M; Pérez-Bacete M; Fenollosa-Entrena B; Llombart-Bosch A
    Urol Int; 1992; 48(1):14-9. PubMed ID: 1376008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial differentiation antigens and epidermal growth factor receptors in transitional cell bladder carcinoma: correlation with prognosis.
    Nakopoulou L; Zervas A; Constantinides C; Deliveliotis C; Stefanaki K; Dimopoulos C
    Urol Int; 1995; 54(4):191-7. PubMed ID: 7541921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunohistochemical localization of epithelial membrane antigen, carcinoembryonic antigen and secretory component in urinary bladder cancer].
    Takashi M; Murase T; Mitsuya H; Koshikawa T; Nagura H; Haimoto H
    Hinyokika Kiyo; 1986 Apr; 32(4):541-52. PubMed ID: 2426931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Keratin, luminal epithelial antigen and carcinoembryonic antigen in human urinary bladder carcinomas. An immunohistochemical study.
    Nathrath WB; Arnholdt H; Wilson PD
    Pathol Res Pract; 1982; 175(2-3):299-307. PubMed ID: 6190152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunohistochemical determination of antigen 19-9 (CA 19-9) in transitional carcinoma of the bladder].
    Casetta G; Cavallini A; Piana P; Squintone L; Vottero M; Tizzani A
    Minerva Urol Nefrol; 1992; 44(3):169-72. PubMed ID: 1492266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical demonstration of tumor-associated antigens with the aid of monoclonal and polyclonal antisera in carcinoma of the bladder.
    Steffens J; Friedmann W; Lobeck H
    Urol Res; 1985; 13(2):55-9. PubMed ID: 2409654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunohistochemical demonstration of tumor-associated antigens in urinary bladder carcinomas using mono- and polyclonal antisera].
    Friedmann W; Steffens J; Lobeck H
    Onkologie; 1985 Apr; 8(2):105-10. PubMed ID: 2582324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue polypeptide antigen in normal and neoplastic urinary bladder. Preliminary reports.
    Senatore S; Attolini A; Luccarelli S; Candita F; Trabucco M
    Oncology; 1987; 44(2):118-23. PubMed ID: 2437508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokeratin 20: a new marker for early detection of bladder cell carcinoma?
    Buchumensky V; Klein A; Zemer R; Kessler OJ; Zimlichman S; Nissenkorn I
    J Urol; 1998 Dec; 160(6 Pt 1):1971-4. PubMed ID: 9817302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial membrane antigen as an immunohistochemical marker for transitional cell carcinoma of the urinary bladder.
    Takashi M; Murase T; Kinjo T; Mitsuya H; Nagura H
    Urol Int; 1987; 42(3):170-5. PubMed ID: 3303592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cell and tumor markers' immunohistochemistry in transitional cell carcinoma of the bladder.
    Lopez-Beltran A; Croghan GA; Croghan I; Gaeta JF
    Urol Int; 1993; 50(2):61-4. PubMed ID: 8460449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunocytochemically demonstrated expression of epithelial membrane antigen and carcinoembryonic antigen by exfoliated urinary cells in patients with bladder cancer.
    Tanaka K; Takashi M; Miyake K; Koshikawa T
    Urol Int; 1994; 52(3):140-4. PubMed ID: 8203052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transitional cell neoplasms of the ovary and urinary bladder: a comparative immunohistochemical analysis.
    Soslow RA; Rouse RV; Hendrickson MR; Silva EG; Longacre TA
    Int J Gynecol Pathol; 1996 Jul; 15(3):257-65. PubMed ID: 8811388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunohistochemical studies on bladder tumours. Evaluation by CEA, ferritin, beta 2-MG, keratin and glycogen].
    Onodera Y
    Nihon Hinyokika Gakkai Zasshi; 1990 Nov; 81(11):1649-53. PubMed ID: 1704938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
    Samaratunga H; Khoo K
    Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transitional cell carcinomas of the ovary and bladder are immunophenotypically different.
    Ordóñez NG
    Histopathology; 2000 May; 36(5):433-8. PubMed ID: 10792484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD15 antigen in urinary bladder transitional cell carcinoma.
    Parham DM; Morton K; Coghill G; Robertson AJ; Kerr MA
    J Clin Pathol; 1990 Jul; 43(7):541-3. PubMed ID: 1974266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Collision of transitional cell carcinoma and renal cell carcinoma. An immunohistochemical study and review of the literature.
    Hart AP; Brown R; Lechago J; Truong LD
    Cancer; 1994 Jan; 73(1):154-9. PubMed ID: 7506117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The immunoperoxidase localization of tumour markers in ovarian cancer: the value of CEA, EMA, cytokeratin and DD9.
    Hammond RH; Bates TD; Clarke DG; Grant AG; Haines AM; Eustace DL; Heyderman E
    Br J Obstet Gynaecol; 1991 Jan; 98(1):73-83. PubMed ID: 1705435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial markers in malignant melanoma. A study of primary lesions and their metastases.
    Ben-Izhak O; Stark P; Levy R; Bergman R; Lichtig C
    Am J Dermatopathol; 1994 Jun; 16(3):241-6. PubMed ID: 7524376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.